|
El Escorial
Criteria for the Diagnosis of
Amyotrophic Lateral Sclerosis (ALS)
The diagnosis of
Amyotrophic Lateral Sclerosis (ALS)
requires:
A. the
presence of:
(A:1) evidence of
lower motor neuron (LMN)
degeneration by
clinical, electrophysiological or
neuropathologic examination,
(A:2) evidence of
upper motor neuron (UMN)
degeneration
by clinical examination,
and
(A:3)
progressive spread of symptoms or
signs within a region or
to other regions, as determined by
history or examination, together
with
B. the
absence of:
(B:1)
electrophysiological and
pathological evidence of other
disease
processes
that might explain the signs of LMN
and/or UMN degeneration, and
(B:2)
neuroimaging evidence of other
disease processes that
might explain the observed clinical
and electrophysiological signs.
Diagnostic
Categories
Clinically Definite ALS:
is
defined on clinical evidence alone
by the presence of UMN, as well as
LMN signs, in three regions.
Clinically Probable ALS:
is
defined on clinical evidence alone
by UMN and LMN signs in at least two
regions with some UMN signs
necessarily rostral to (above) the
LMN signs.
The terms
Clinically Probable ALS -
Laboratory-supported and Clinically
Possible ALS are used to describe
these categories of clinical
certainty on clinical and criteria
or only clinical criteria:
Clinically Probable -
Laboratory-supported ALS:
is
defined when clinical signs of UMN
and LMN dysfunction are in only one
region, or when UMN signs alone are
present in one region, and LMN signs
defined by EMG criteria are present
in at least two limbs, with proper
application of neuroimaging and
clinical laboratory protocols to
exclude other causes.
Clinically Possible ALS:
is
defined when clinical signs of UMN
and LMN dysfunction are found
together in only one region or UMN
signs are found alone in two or more
regions; or LMN signs are found
rostral to UMN signs and the
diagnosis of Clinically Probable -
Laboratory-supported ALS cannot be
proven by evidence on clinical
grounds in conjunction with
electrodiagnostic, neurophysiologic,
neuroimaging or clinical laboratory
studies. Other diagnoses must have
been excluded to accept a diagnosis
of Clinically possible ALS.
Clinically Suspected ALS:
it is a
pure LMN syndrome, wherein the
diagnosis of ALS could not be
regarded as sufficiently certain to
include the patient in a research
study. Hence, this category is
deleted from the revised El Escorial
Criteria for the Diagnosis of ALS.
-
Brooks BR. El Escorial
World Federation of
Neurology criteria for
the diagnosis of
amyotrophic lateral
sclerosis.
Subcommittee on Motor
Neuron
Diseases/Amyotrophic
Lateral Sclerosis of
the World Federation
of Neurology Research
Group on Neuromuscular
Diseases and the El
Escorial "Clinical
limits of amyotrophic
lateral sclerosis"
workshop contributors.
J Neurol Sci. 1994
Jul;124 Suppl:96-107.
[Medline]
-
Mitsumoto H. Diagnosis
and progression of ALS.
Neurology 1997;
48(S4):2S-8S.
-
Ross MA, Miller RG,
Berchert L, Parry G,
Barohn RJ, Armon C,
Bryan WW, Petajan J,
Stromatt S,
Goodpasture J, McGuire
D. Toward earlier
diagnosis of
amyotrophic lateral
sclerosis: revised
criteria. rhCNTF ALS
Study Group.
Neurology. 1998
Mar;50(3):768-72.
[Medline]
Sponsored Links
|